PR

Precision Biosensor Inc.

Develops sensitive point-of-care biomarker diagnostics for human and animal health.

335810 | KO

Overview

Corporate Details

ISIN(s):
KR7335810008
LEI:
Country:
South Korea
Address:
대전시 유성구 테크노2로 306, 대전시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Precision Biosensor Inc. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells point-of-care testing (POCT) solutions. The company specializes in biomarker diagnostics, offering a range of clinical diagnostic products for both human and animal healthcare. Its core offerings are built upon a proprietary time-resolved fluorescence (TRF) immunoassay technology, designed to deliver highly sensitive and accurate results for on-site diagnosis. The product line includes diagnostic devices and reagents for immuno-diagnosis and clinical chemistry, aiming to provide optimized solutions for rapid clinical decision-making.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-09-01 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 5.9 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-07-31 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 89.6 KB
2025-07-31 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.8 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-05-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 22.4 KB
2025-05-12 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 22.1 KB
2025-04-02 00:00
Post-Annual General Meeting Information
[기재정정]정기주주총회결과
Korean 23.2 KB
2025-03-27 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 19.9 KB
2025-03-27 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.1 KB
2025-03-27 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 17.8 KB
2025-03-19 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 491.4 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 25.8 KB
2025-03-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 156.0 KB

Automate Your Workflow. Get a real-time feed of all Precision Biosensor Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Precision Biosensor Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Precision Biosensor Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

NEOGEN CORP Logo
Provides diagnostic tests and genomics services for food, animal, and agricultural safety.
United States of America
NEOG
NEOGENOMICS INC Logo
Provides precision oncology testing for cancer diagnostics, therapy guidance, and research.
United States of America
NEO
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America
950220
NEONC TECHNOLOGIES HOLDINGS, INC. Logo
Developing intranasal drug delivery to treat brain cancer & CNS diseases by crossing the BBB.
United States of America
NTHI
Neumora Therapeutics, Inc. Logo
Developing data-driven precision medicines for neuropsychiatric and neurodegenerative disorders.
United States of America
NMRA
Neuphoria Therapeutics Inc. Logo
Develops novel ion channel modulators for treating neuropsychiatric disorders like anxiety & PTSD.
United States of America
NEUP
NEUROCRINE BIOSCIENCES INC Logo
Develops therapies for neurological, neuroendocrine, and neuropsychiatric disorders.
United States of America
NBIX
Neurogene Inc. Logo
Developing genetic medicines using gene therapy for rare and devastating neurological diseases.
United States of America
NGNE
NeuroSense Therapeutics Ltd. Logo
Developing combination therapies for neurodegenerative diseases, with a focus on ALS.
United States of America
NRSN
NewAmsterdam Pharma Co N.V. Logo
Developing oral LDL-lowering therapies for high-risk cardiovascular disease patients.
United States of America
NAMS

Talk to a Data Expert

Have a question? We'll get back to you promptly.